FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
About | Sample | Privacy

Nobel Prize goes to gene targeting trio

As a child, Mario Capecchi spent four years on the streets in his native Italy, surviving by stealing or begging for food. Today, he's one of three scientists--the other two are Oliver Smithies and Sir Martin Evans--who've won the Nobel prize for medicine, recognition for their collective work on gene targeting, a process that allows researchers to turn genes off and on in mice. Their work involved introducing a genetic alteration in embryonic stem cells which are then injected into a mouse embryo. That development has spurred a huge advance in understanding the role of genes and health--and advanced a myriad number of therapeutic programs.

- see the release from the Nobel Assembly
- read the article from the New York Times

Related Article:
Gene therapy makes a big comeback. Report

More stories about embryonic stem cells   genes   gene therapy   Nobel Prize   Mario Capecchi   Oliver Smithies   Martin Evans   gene targeting  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 33 + 27?
To combat spam, please solve the math question above.